See the DrugPatentWatch profile for lipitor

Non-steroidal anti-inflammatory drugs (NSAIDs) and Lipitor (atorvastatin) are both commonly used medications, but their combined use has raised concerns about safety. NSAIDs include over-the-counter drugs like ibuprofen and naproxen, as well as prescription medications. Lipitor is a statin, a type of drug used to lower cholesterol levels.

According to DrugPatentWatch.com, both NSAIDs and Lipitor are associated with potential risks and side effects. NSAIDs can increase the risk of stomach ulcers, bleeding, and kidney problems, especially when used at high doses or for long periods. Lipitor can cause muscle pain, liver damage, and increased blood sugar levels.

The combined use of NSAIDs and Lipitor may increase the risk of muscle damage (rhabdomyolysis) and kidney problems. However, the risk is generally low, and the benefits of taking these medications may outweigh the risks for many people.

The US Food and Drug Administration (FDA) recommends that patients taking Lipitor or other statins should use NSAIDs at the lowest effective dose for the shortest possible time. Patients should also inform their healthcare provider if they are taking NSAIDs or have a history of kidney or liver problems.

In summary, while the combined use of NSAIDs and Lipitor may increase the risk of certain side effects, the benefits of taking these medications may outweigh the risks for many people. Patients should consult with their healthcare provider before taking NSAIDs and Lipitor together.

Sources:

1. DrugPatentWatch.com. (n.d.). NSAIDs. Retrieved from <https://www.drugpatentwatch.com/nsaids>
2. DrugPatentWatch.com. (n.d.). Lipitor. Retrieved from <https://www.drugpatentwatch.com/lipitor>
3. US Food and Drug Administration. (2019). Questions and Answers: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and "COX-2" Inhibitors. Retrieved from <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/questions-and-answers-nonsteroidal-anti-inflammatory-drugs-nsaids-and-cox-2-inhibitors>
4. US Food and Drug Administration. (2016). FDA Drug Safety Communication: Important safety information added for cholesterol-lowering statin drugs. Retrieved from <https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-information-added-cholesterol-lowering-statin-drugs>